Most quit breakthrough weight-loss drug within a year
A massive Danish study reveals that despite the remarkable weight-loss benefits of semaglutide, more than half of adults without diabetes stop using it within a year. High costs, unpleasant side effects, and underlying medical or psychiatric conditions play major roles in the dropouts. Younger users and men are especially prone to quitting, raising concerns since …
Most quit breakthrough weight-loss drug within a year Read More »